ICD-10: | D17.22 |
---|---|
Short Description: | Benign lipomatous neoplasm of skin, subcu of left arm |
Long Description: | Benign lipomatous neoplasm of skin and subcutaneous tissue of left arm |
A benign, usually painless, well-circumscribed lipomatous tumor composed of adipose tissue. Skin biopsy, diagnostic of pss: skin biopsy revealing increased compact collagen in the reticular dermis, thinning of the epidermis, loss of rete pegs, atrophy of dermal appendages, and hyalinization and fibrosis of arterioles.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
A benign neoplasm composed of adipose tissue. A benign tumor composed of adipose (fatty) tissue. The most common representative of this category is the lipoma. A benign tumor composed of fat cells (adipocytes). It can be surrounded by a thin layer of connective tissue (encapsulated), or diffuse without the capsule.
The 2022 edition of ICD-10-CM D17.9 became effective on October 1, 2021.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk 1 D17.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 Short description: Benign lipomatous neoplasm of skin, subcu of trunk 3 The 2021 edition of ICD-10-CM D17.1 became effective on October 1, 2020. 4 This is the American ICD-10-CM version of D17.1 - other international versions of ICD-10 D17.1 may differ.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM D17.1 became effective on October 1, 2021.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM D17.79 became effective on October 1, 2021.
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.
Benign lipomatous neoplasm of skin and subcutaneous tissue of limb 1 D17.2 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. 2 Short description: Benign lipomatous neoplasm of skin, subcu of limb 3 The 2021 edition of ICD-10-CM D17.2 became effective on October 1, 2020. 4 This is the American ICD-10-CM version of D17.2 - other international versions of ICD-10 D17.2 may differ.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
The 2022 edition of ICD-10-CM D17.2 became effective on October 1, 2021.
However, when the lipoma is in a deep subcutaneous, subfascial, or submuscular location, an appropriate code from the musculoskeletal system (eg 21930, Excision, tumor, soft tissue of back or flank) would be reported to describe more closely the work entailed.
There is a newer CPT Assistant Article from August 2006 that states, "When a lipoma is present in a superficial location, it would be appropriate to use an excision code from the integumentary system (eg, 11400-11446, Excision, benign lesion). However, when the lipoma is in a deep subcutaneous, subfascial, or submuscular location, an appropriate code from the musculoskeletal system (eg 21930, Excision, tumor, soft tissue of back or flank) would be reported to describe more closely the work entailed. Therefore it is necessary to consult the procedure report to determine the physician work involved in removing the lipoma.
Going way back to an article that was published in the Coding Edge in May of 2003 by a Mary Nell Waldrup, CPC, CCP stated the following under the heading Lipomas, "Lipomas originate in the subcutaneous tissue and are coded, according to site, from the soft tissue excision codes, which are found in the Musculoskeletal section or from codes in the Integumentary section of CPT (R). Do not bill repair separately since the soft tissue site specific codes include the work required for repair. Small lipomas of less than 2 centimeters may be coded with the excision and repair codes from the benign lesion excision section of CPT (R), as appropriate, depending on the required repair. The AMA CPT (R) Assistant, August 2002, states, 'When lipomas are excised from skin or subcutaneous tissue, it would be appropriate to utilize the integumentary system excision of benign lesion codes (11400-11446). When the lesions are located in deep subfascial or submuscular tissues, the appropriate code from the musculoskeletal system should be reported to describe the work entailed.
The procedure code (CPT) that is chosen is based on the procedure performed. It would be up the the surgeon to prove the medical necessity of the procedure if it were denied for diagnosis.
I have this same circumstance and talked it over with my doctor and he and I both concluded 27327, because a Lipoma is equal to a tumor.